Highlights
KLSE: ALLIANZ (1163)       ALLIANZ MALAYSIA BHD MAIN : Finance
Last Price Today's Change   Day's Range   Trading Volume
21.00   +0.04 (0.19%)  20.86 - 21.00  5,000
Trade this stock with T+7 trading account. Find out more.

Financials


Market Cap: 3,737 Million

Market Cap 3,737 Million
NOSH 178 Million

Latest Audited Result:  31-Dec-2023

Latest Audited Result: 31-Dec-2023
Announcement Date 29-Feb-2024
Next Audited Result: 31-Dec-2024
Est. Ann. Date: 28-Feb-2025
Est. Ann. Due Date: 29-Jun-2025

Latest Quarter:  31-Dec-2023 [#4]

Latest Quarter: 31-Dec-2023 [#4]
Announcement Date 26-Feb-2024
Next Quarter: 31-Mar-2024
Est. Ann. Date: 29-May-2024
Est. Ann. Due Date: 30-May-2024
QoQ | YoY   -2.11%  |    16.44%

Annual (Unaudited) ( EPS: 296.69, P/E: 5.11 )

Revenue | NP to SH 4,941,641  |  730,908
RPS | P/RPS 2,776.68 Cent  |  0.76
EPS | P/E | EY 296.69 Cent  |  5.11  |  19.56%
DPS | DY | Payout % 100.50 Cent  |  4.79%  |  24.47%
NAPS | P/NAPS 28.88  |  0.73
YoY   54.58%
NP Margin | ROE 14.79%  |  14.22%
F.Y. | Ann. Date 31-Dec-2023  |  26-Feb-2024

T4Q Result ( EPS: 410.69, P/E: 5.11 )

Revenue | NP to SH 4,941,641  |  730,908
RPS | P/RPS 2,776.68 Cent  |  0.76
EPS | P/E | EY 410.69 Cent  |  5.11  |  19.56%
DPS | DY | Payout % 132.00 Cent  |  6.29%  |  32.14%
NAPS | P/NAPS 28.88  |  0.73
QoQ | YoY   3.89%  |    54.58%
NP Margin | ROE 14.79%  |  14.22%
F.Y. | Ann. Date 31-Dec-2023  |  26-Feb-2024

Annualized Result ( EPS: 296.69, P/E: 5.11 )

Revenue | NP to SH 4,941,641  |  730,908
RPS | P/RPS 2,776.68 Cent  |  0.76
EPS | P/E | EY 296.69 Cent  |  5.11  |  19.56%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   2.04%  |    54.58%
NP Margin | ROE 14.79%  |  14.22%
F.Y. | Ann. Date 31-Dec-2023  |  26-Feb-2024


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2023 26-Feb-2024 31-Dec-2023 4 1,309,506 239,364 193,691 193,691 122,798 5,139,751 63.40% 14.79% 3.77% 177,969 735.80 735.80 30.56 30.56 69.00 69.00 28.8800 28.88   -2.11%   16.44% 29-Dec-2023 18.44 2.51 16.94 0.64 5.90% 3.74% 26-Feb-2024 18.56 2.52 17.05 0.64 5.86% 3.72%
31-Dec-2023 23-Nov-2023 30-Sep-2023 3 1,306,012 262,360 197,857 197,857 - 5,162,887 - % 15.15% 3.83% 177,969 733.84 733.84 111.17 111.17 0.00 0.00 29.0100 29.01   18.71%   82.26% 29-Sep-2023 15.90 2.17 14.30 0.55 6.99% 0.00% 23-Nov-2023 17.88 2.44 16.08 0.62 6.22% 0.00%
31-Dec-2023 23-Aug-2023 30-Jun-2023 2 1,164,749 222,876 166,674 166,674 56,060 4,986,698 33.63% 14.31% 3.34% 177,969 654.47 654.47 57.92 57.92 31.50 31.50 28.0200 28.02   -3.48%   72.50% 30-Jun-2023 14.30 2.18 15.27 0.51 6.55% 2.20% 23-Aug-2023 16.42 2.51 17.53 0.59 5.70% 1.92%
31-Dec-2023 29-May-2023 31-Mar-2023 1 1,161,374 232,289 172,686 172,686 56,060 4,917,289 32.46% 14.87% 3.51% 177,969 652.57 652.57 97.03 97.03 31.50 31.50 27.6300 27.63   3.82%   70.44% 31-Mar-2023 13.74 2.11 14.16 0.50 7.06% 2.29% 14.00 2.15 14.43 0.51 6.93% 2.25%
31-Dec-2022 23-Feb-2023 31-Dec-2022 4 1,703,900 267,482 166,338 166,338 122,482 4,219,436 73.63% 9.76% 3.94% 177,511 959.88 957.41 15.23 93.46 69.00 68.82 23.7700 23.71   53.23%   7.54% 30-Dec-2022 14.16 1.48 15.11 0.60 6.62% 4.87% 13.88 1.45 14.81 0.58 6.75% 4.97%
31-Dec-2022 23-Nov-2022 30-Sep-2022 3 1,706,909 166,503 108,558 108,558 - 4,280,129 - % 6.36% 2.54% 177,894 959.51 959.10 61.02 61.00 0.00 0.00 24.0600 24.05   12.36%   -5.73% 30-Sep-2022 13.30 1.39 21.79 0.55 4.59% 0.00% 23-Nov-2022 13.30 1.39 21.79 0.55 4.59% 0.00%
31-Dec-2022 24-Aug-2022 30-Jun-2022 2 1,654,503 118,641 96,620 96,620 28,458 4,183,384 29.45% 5.84% 2.31% 177,865 930.20 929.66 36.16 54.29 16.00 15.99 23.5200 23.51   -4.63%   -33.55% 30-Jun-2022 12.88 1.38 23.71 0.55 4.22% 1.24% 24-Aug-2022 13.20 1.42 24.30 0.56 4.12% 1.21%
31-Dec-2022 20-May-2022 31-Mar-2022 1 1,707,677 151,800 101,315 101,315 - 4,197,385 - % 5.93% 2.41% 177,780 960.56 959.53 56.99 56.93 0.00 0.00 23.6100 23.58   -34.50%   60.16% 31-Mar-2022 12.72 1.32 22.32 0.54 4.48% 0.00% 20-May-2022 12.60 1.31 22.11 0.53 4.52% 0.00%
31-Dec-2021 22-Feb-2022 31-Dec-2021 4 1,671,277 193,025 154,674 154,674 111,714 4,140,538 72.23% 9.25% 3.74% 177,325 942.49 939.08 15.37 86.91 63.00 62.77 23.3500 23.27   34.32%   7.39% 31-Dec-2021 12.86 1.36 14.74 0.55 6.78% 4.90% 12.66 1.34 14.51 0.54 6.89% 4.98%
31-Dec-2021 24-Nov-2021 30-Sep-2021 3 1,584,546 158,902 115,155 115,155 - 4,249,041 - % 7.27% 2.71% 177,265 893.89 890.35 64.96 64.71 0.00 0.00 23.9700 23.88   -20.81%   -10.78% 30-Sep-2021 12.78 1.43 19.67 0.53 5.08% 0.00% 24-Nov-2021 13.00 1.45 20.01 0.54 5.00% 0.00%
31-Dec-2021 25-Aug-2021 30-Jun-2021 2 1,568,664 206,279 145,410 145,410 - 4,151,622 - % 9.27% 3.50% 176,966 886.42 881.42 82.17 81.71 0.00 0.00 23.4600 23.33   129.87%   -13.31% 30-Jun-2021 13.00 1.47 15.82 0.55 6.32% 0.00% 25-Aug-2021 12.66 1.43 15.41 0.54 6.49% 0.00%
31-Dec-2021 19-May-2021 31-Mar-2021 1 1,606,552 67,380 63,258 63,258 - 3,994,370 - % 3.94% 1.58% 176,977 907.77 902.71 35.74 35.54 0.00 0.00 22.5700 22.44   -56.08%   -20.43% 31-Mar-2021 13.50 1.49 37.77 0.60 2.65% 0.00% 19-May-2021 13.16 1.45 36.82 0.58 2.72% 0.00%
31-Dec-2020 24-Feb-2021 31-Dec-2020 4 1,526,097 186,854 144,028 144,028 102,595 4,031,296 71.23% 9.44% 3.57% 176,888 862.74 857.51 14.80 80.93 58.00 57.65 22.7900 22.65   11.59%   8.23% 31-Dec-2020 14.78 1.71 18.15 0.65 5.51% 3.92% 13.76 1.59 16.90 0.60 5.92% 4.22%
31-Dec-2020 26-Nov-2020 30-Sep-2020 3 1,530,803 202,231 129,065 129,065 - 4,121,509 - % 8.43% 3.13% 176,888 865.40 860.15 72.96 72.52 0.00 0.00 23.3000 23.16   -23.05%   -9.63% 30-Sep-2020 13.66 1.58 18.72 0.59 5.34% 0.00% 26-Nov-2020 13.70 1.58 18.78 0.59 5.33% 0.00%
31-Dec-2020 27-Aug-2020 30-Jun-2020 2 1,404,105 248,598 167,732 167,732 - 3,965,873 - % 11.95% 4.23% 176,890 793.77 788.96 94.82 94.25 0.00 0.00 22.4200 22.28   110.98%   42.55% 30-Jun-2020 14.10 1.78 14.87 0.63 6.73% 0.00% 27-Aug-2020 13.48 1.70 14.22 0.60 7.03% 0.00%
31-Dec-2020 16-Jun-2020 31-Mar-2020 1 1,484,706 91,947 79,500 79,500 - 3,739,429 - % 5.35% 2.13% 176,888 839.34 834.25 44.94 44.67 0.00 0.00 21.1400 21.01   -40.26%   -19.63% 31-Mar-2020 12.48 1.49 27.77 0.59 3.60% 0.00% 16-Jun-2020 14.30 1.70 31.82 0.68 3.14% 0.00%
31-Dec-2019 27-Feb-2020 31-Dec-2019 4 1,405,471 188,158 133,082 133,082 114,851 3,669,934 86.30% 9.47% 3.63% 176,694 795.43 789.73 0.57 74.78 65.00 64.53 20.7700 20.62   -6.81%   33.03% 31-Dec-2019 16.28 2.05 21.62 0.78 4.63% 3.99% 27-Feb-2020 15.70 1.97 20.85 0.76 4.80% 4.14%
31-Dec-2019 27-Nov-2019 30-Sep-2019 3 1,418,593 175,031 142,812 142,812 - 3,788,212 - % 10.07% 3.77% 176,689 802.88 797.10 80.83 80.25 0.00 0.00 21.4400 21.29   21.37%   42.99% 30-Sep-2019 13.84 1.72 17.12 0.65 5.84% 0.00% 27-Nov-2019 14.00 1.74 17.32 0.65 5.77% 0.00%
31-Dec-2019 22-Aug-2019 30-Jun-2019 2 1,366,015 177,715 117,667 117,667 - 3,628,616 - % 8.61% 3.24% 176,747 772.86 767.56 66.57 66.12 0.00 0.00 20.5300 20.39   18.96%   30.93% 28-Jun-2019 14.00 1.81 21.03 0.68 4.76% 0.00% 22-Aug-2019 13.80 1.79 20.73 0.67 4.82% 0.00%
31-Dec-2019 23-May-2019 31-Mar-2019 1 1,344,295 151,240 98,917 98,917 - 3,485,076 - % 7.36% 2.84% 176,728 760.66 755.35 55.97 55.58 0.00 0.00 19.7200 19.58   -1.12%   13.40% 29-Mar-2019 14.50 1.91 25.91 0.74 3.86% 0.00% 23-May-2019 13.18 1.73 23.55 0.67 4.25% 0.00%
31-Dec-2018 21-Feb-2019 31-Dec-2018 4 1,302,173 127,837 100,040 100,040 69,838 3,322,561 69.81% 7.68% 3.01% 174,596 745.82 731.68 10.69 56.21 40.00 39.24 19.0300 18.67   0.16%   15.28% 31-Dec-2018 13.00 1.74 22.69 0.68 4.41% 3.08% 21-Feb-2019 14.00 1.88 24.43 0.74 4.09% 2.86%
31-Dec-2018 22-Nov-2018 30-Sep-2018 3 1,301,578 147,676 99,879 99,879 - 3,414,808 - % 7.67% 2.92% 176,658 736.78 731.35 56.54 56.12 0.00 0.00 19.3300 19.19   11.14%   47.91% 28-Sep-2018 12.80 1.74 22.64 0.66 4.42% 0.00% 22-Nov-2018 12.00 1.63 21.22 0.62 4.71% 0.00%
31-Dec-2018 20-Aug-2018 30-Jun-2018 2 1,306,772 115,841 89,870 89,870 - 3,266,391 - % 6.88% 2.75% 174,954 746.92 734.27 51.37 50.50 0.00 0.00 18.6700 18.35   3.02%   35.18% 29-Jun-2018 12.70 1.70 24.72 0.68 4.04% 0.00% 20-Aug-2018 12.60 1.69 24.53 0.67 4.08% 0.00%
31-Dec-2018 28-May-2018 31-Mar-2018 1 1,271,406 127,630 87,232 87,232 - 3,215,121 - % 6.86% 2.71% 175,211 725.64 714.40 49.79 49.02 0.00 0.00 18.3500 18.07   0.52%   29.86% 30-Mar-2018 11.62 1.60 23.34 0.63 4.28% 0.00% 28-May-2018 13.16 1.81 26.43 0.72 3.78% 0.00%
31-Dec-2017 22-Feb-2018 31-Dec-2017 4 1,209,867 126,385 86,782 86,782 20,851 3,120,801 24.03% 7.17% 2.78% 173,764 696.27 679.82 49.94 48.76 12.00 11.72 17.9600 17.54   28.52%   -3.55% 29-Dec-2017 13.50 1.94 27.03 0.75 3.70% 0.89% 22-Feb-2018 13.10 1.88 26.23 0.73 3.81% 0.92%
31-Dec-2017 22-Nov-2017 30-Sep-2017 3 1,188,389 97,248 67,526 67,526 - 3,094,723 - % 5.68% 2.18% 174,350 681.61 667.75 38.73 37.94 0.00 0.00 17.7500 17.39   1.57%   -7.10% 29-Sep-2017 14.04 2.06 36.25 0.79 2.76% 0.00% 22-Nov-2017 14.00 2.05 36.15 0.79 2.77% 0.00%
31-Dec-2017 17-Aug-2017 30-Jun-2017 2 1,193,797 104,987 66,480 66,480 - 3,022,292 - % 5.57% 2.20% 173,894 686.51 670.79 38.23 37.35 0.00 0.00 17.3800 16.98   -1.03%   -12.86% 30-Jun-2017 12.90 1.88 33.74 0.74 2.96% 0.00% 17-Aug-2017 14.52 2.12 37.98 0.84 2.63% 0.00%
31-Dec-2017 30-May-2017 31-Mar-2017 1 1,208,937 108,663 67,174 67,174 - 2,949,610 - % 5.56% 2.28% 173,710 695.95 679.30 38.67 37.74 0.00 0.00 16.9800 16.57   -25.34%   -8.21% 31-Mar-2017 11.56 1.66 29.89 0.68 3.35% 0.00% 30-May-2017 12.52 1.80 32.38 0.74 3.09% 0.00%
31-Dec-2016 24-Feb-2017 31-Dec-2016 4 1,210,975 121,004 89,979 89,979 15,293 2,817,472 17.00% 7.43% 3.19% 169,932 712.62 680.44 52.95 50.56 9.00 8.59 16.5800 15.83   23.79%   4.31% 30-Dec-2016 10.20 1.43 19.26 0.62 5.19% 0.88% 24-Feb-2017 11.22 1.57 21.19 0.68 4.72% 0.80%
31-Dec-2016 29-Nov-2016 30-Sep-2016 3 1,152,180 109,271 72,684 72,684 - 2,807,783 - % 6.31% 2.59% 169,347 680.36 647.40 42.92 40.84 0.00 0.00 16.5800 15.78   -4.73%   -7.42% 30-Sep-2016 10.10 1.48 23.53 0.61 4.25% 0.00% 29-Nov-2016 9.79 1.44 22.81 0.59 4.38% 0.00%
31-Dec-2016 18-Aug-2016 30-Jun-2016 2 1,148,446 109,319 76,289 76,289 - 2,725,213 - % 6.64% 2.80% 169,795 676.37 645.31 44.93 42.87 0.00 0.00 16.0500 15.31   4.25%   8.28% 30-Jun-2016 10.06 1.49 22.39 0.63 4.47% 0.00% 18-Aug-2016 10.22 1.51 22.75 0.64 4.40% 0.00%
31-Dec-2016 27-May-2016 31-Mar-2016 1 1,167,293 114,997 73,179 73,179 - 2,710,772 - % 6.27% 2.70% 169,317 689.41 655.90 43.22 41.12 0.00 0.00 16.0100 15.23   -15.17%   -0.63% 31-Mar-2016 10.72 1.55 24.80 0.67 4.03% 0.00% 27-May-2016 9.92 1.44 22.95 0.62 4.36% 0.00%
31-Dec-2015 26-Feb-2016 31-Dec-2015 4 1,170,453 127,000 86,264 86,264 10,887 2,592,945 12.62% 7.37% 3.33% 167,502 698.77 657.67 51.50 48.47 6.50 6.12 15.4800 14.57   9.88%   21.41% 31-Dec-2015 10.50 1.50 20.39 0.68 4.90% 0.62% 26-Feb-2016 9.93 1.42 19.28 0.64 5.19% 0.65%
31-Dec-2015 20-Nov-2015 30-Sep-2015 3 1,135,434 97,365 78,508 78,508 - 2,489,073 - % 6.91% 3.15% 167,501 677.86 637.99 46.87 44.11 0.00 0.00 14.8600 13.99   11.43%   0.11% 30-Sep-2015 10.60 1.56 22.62 0.71 4.42% 0.00% 20-Nov-2015 10.52 1.55 22.45 0.71 4.46% 0.00%
31-Dec-2015 26-Aug-2015 30-Jun-2015 2 1,113,620 101,437 70,458 70,458 - 2,433,637 - % 6.33% 2.90% 167,837 663.51 625.74 41.98 39.59 0.00 0.00 14.5000 13.67   -4.32%   17.01% 30-Jun-2015 11.78 1.78 28.06 0.81 3.56% 0.00% 26-Aug-2015 10.18 1.53 24.25 0.70 4.12% 0.00%
31-Dec-2015 27-May-2015 31-Mar-2015 1 1,099,990 112,419 73,641 73,641 - 2,378,602 - % 6.69% 3.10% 167,861 655.29 618.08 43.87 41.38 0.00 0.00 14.1700 13.37   3.64%   -14.59% 31-Mar-2015 12.54 1.91 28.58 0.88 3.50% 0.00% 27-May-2015 12.80 1.95 29.18 0.90 3.43% 0.00%
31-Dec-2014 27-Feb-2015 31-Dec-2014 4 1,225,085 100,005 71,052 71,052 8,039 2,197,965 11.31% 5.80% 3.23% 160,787 761.93 688.37 44.19 39.92 5.00 4.52 13.6700 12.35   -9.39%   48.42% 31-Dec-2014 11.42 1.50 25.84 0.84 3.87% 0.44% 27-Feb-2015 12.30 1.61 27.83 0.90 3.59% 0.41%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 1,058,334 112,058 78,418 78,418 - 2,161,810 - % 7.41% 3.63% 161,088 656.99 594.67 48.68 44.06 0.00 0.00 13.4200 12.15   30.23%   5.75% 30-Sep-2014 11.92 1.81 24.49 0.89 4.08% 0.00% 21-Nov-2014 12.00 1.83 24.65 0.89 4.06% 0.00%
31-Dec-2014 28-Aug-2014 30-Jun-2014 2 1,076,235 87,457 60,215 60,215 - 2,103,545 - % 5.59% 2.86% 162,435 662.56 604.73 37.07 33.83 0.00 0.00 12.9500 11.82   -30.16%   -3.15% 30-Jun-2014 12.70 1.92 34.26 0.98 2.92% 0.00% 28-Aug-2014 12.98 1.96 35.01 1.00 2.86% 0.00%
31-Dec-2014 28-May-2014 31-Mar-2014 1 1,016,530 124,010 86,217 86,217 - 2,086,314 - % 8.48% 4.13% 162,612 625.13 571.18 53.02 48.44 0.00 0.00 12.8300 11.72   80.10%   60.49% 31-Mar-2014 10.26 1.64 19.35 0.80 5.17% 0.00% 28-May-2014 10.40 1.66 19.62 0.81 5.10% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  7 people like this.
 
observatory Thanks for explaining. It's not easy to estimate future growth based on quarter to quarter CSM number. Is NBV still the best indicator of growth?
25/11/2023 11:17 AM
moven00 Lagi Sekali….. ✅💪🏻
02/12/2023 2:44 PM
wsb_investor Allianz on viagra again
18/12/2023 11:37 AM
myongcc5 HAPPY NEW YEAR!
Fellow ALLIANZ Holders
29/12/2023 5:05 PM
ongkkh declare div d, nobody mentioned it?
10/01/2024 7:02 AM
troy88 Good fundamental stock that is low profile and held mainly by long term holders..
10/01/2024 10:24 AM
wsb_investor dividend payment before CNY, huat ar
10/01/2024 10:50 AM
wsb_investor I foresee there will be another small bump in share price when YE23 result is out. Then throughout entire 2024 will be rather stable.

Future spike will depend on medical business management (how often Allianz will do the repricing), medical inflation, MOH policies, and new business market share.
10/01/2024 10:56 AM
observatory @wsb, how big is the medical business contribution in terms of premium and profit? How might MOH policies affect it?
10/01/2024 12:09 PM
wsb_investor No idea with Allianz, but can easily guess from Prudential and GE. Prudential with 73% claims from medical and GE with 55% claims from medical.

Total claims paid by Allianz Life = ~1.7bil in 2022, medical claims estimated to be ~0.9bil-1.2bil.
Margin usually in the range of 20%, i.e. 0.3bil (cost of insurance for medical - claims paid), depending on the repricing cycle, will be more profitable when it is just "freshly" reprice, will be least profitable when the last reprice is long time ago.
vs IFRS17 full year profit of 0.4bil.

If BNM delay repricing approval for one year, assuming 10% inflation, it will wipe out ~120mil profit for Allianz.

Nobody will happy with medical inflation, people will eventually drop coverage when it is not supportable. The key issue is because customers like cashless admission, not knowing the consequences of it. Singapore has already mandatory all medical insurance to have coinsurance/deductible. Suspect Malaysia will soon follow, if BNM/MOH is smart. However, changing to coinsurance/deductible, while will make medical business more sustainable, it will have immediate short term effect where the COI collected will reduce, and impact the short term profit.

Another key change is the rumor that government will end the RM1 treatment for government hospital, and will launch something like Singapore medishield/social insurance/社保.
This will change the landscape dramatically. e.g. can people with private medical insurance opt-out? (if can, then this social insurance will be a failure with substandard life)
If cannot opt out, then majority will have 2 insurances (or 3 if included insurance from employer).
People might drop out from the private medical insurance as well.
Regardless, personally I dont think social insurance (in any form) in Malaysia will success, especially under leadership of Anwar.
10/01/2024 2:15 PM
wsb_investor Cost of insurance for medical, will increase over time, as policyholder ages, and due to medical inflation. Assuming nothing will change, the yearly absolute margin from medical business will grow at at least 2x of inflation rate.

Some might say, CSM (PV profit) should already capture all these and current reporting should already reflecting all these, but actually is no. Actuaries will not project medical inflation (~8% p.a.) until end of policy term, as it will give very extremely high number that very hard to explain.
10/01/2024 2:20 PM
observatory Thanks for the explanation. Your point that medical inflation is not projected by actuaries and not reflected in CSM is important one.
10/01/2024 4:11 PM
troy88 this underrated stock should enter the RM20+ region eventually..
11/01/2024 9:51 AM
sheldon Any reason why the preference and ordinary share price is converging?
12/01/2024 5:04 PM
yielder medical insurance should be a loss leader for insurer? they might not make any money from medical insurance. but to use it as a lead generator, to sell high margin investment linked products
13/01/2024 1:56 PM
wsb_investor break 20 tomorrow?
maybe 22 when YE23 results out.

Medical business might be a loss if there is no reprice for a while, but usually will have 20-30% margin upon repricing (reflecting next 2-3 years inflation). e.g. first year after repricing 30% margin, second year 20% margin, third year 10% margin, then another round of repricing again. Margin on medical insurance is the key source of profit for big4 players.
15/01/2024 4:04 PM
wsb_investor A sense of how medical COI rates exponentially increasing as we age, age 50 COI = 153% of age 40 COI, age 60 COI = 180% of age 50 COI, age 70 COI = 233% of age 60 COI, and all these before medical inflation.
https://www.prudential.com.my/export/sites/prudential-pamb/.galleries/pdf/en/listing/PRUMillion-Med-COI.pdf

Current average age of policyholder for big4 should be ~age40.
Under IFRS4, future margin doesn't include in profit calculation, under IFRS17, a portion of future margin is included in profit calculation.
15/01/2024 4:13 PM
wsb_investor The first real round of medical repricing started in ~2015/2016. Prior to that, yes, many life insurance operate at a loss on their medical business. Because of that, previously there is no fancy million dollar limit / unlimited coverage, sort of like limit the coverage in order to minimize losses.
After 2015/2016, BNM is more "open" to actuarially sounded medical repricing, and then we started to see fancy medical coverage.
15/01/2024 4:16 PM
sheldon My 2 sen take - The medical insurance industry is a rip-off. Not much actuarial science in it because the insured bears the risk if the insurance co has not enough funds to meet their promised cumulative coverage.

Mine is a case in point. I bought cumulative lifetime coverage of up to 660k for a monthly premium of 250. Several years later, they tell me that my 250 per month may not be sufficient to cover the 660k and advised that I increase it. My argument is that I'm not asking for an increased cumulative cover. It seems that my insurer has a right to the effect of withdrawing my coverage if I don't increase my premium. Wow! This is such a wonderful deal for insurers.
15/01/2024 10:02 PM
wsb_investor Nowhere on earth that medical insurance rate is fixed, simply because you will not able to price in all future inflation, hence naturally it will only be short term basis, and will require frequent repricing. Medical insurance margin, in % is actually one of the lowest, and it is a lot harder to manage it vs say death claims.
15/01/2024 11:37 PM
sheldon wsb_investor - Tq for your response but I beg to disagree.

The 660k is not adjusted upward for inflation hence logically in all fairness my 250 premium should correspondingly remain. If I seek to increase my cumulative coverage, then by all means I welcome an increase in premium.
16/01/2024 9:20 AM
wsb_investor 660k is your annual limit. 99% of the claims, the amount will not exceed 100k, but the average claims amount will keep increasing. 660k annual limit, or unlimited limit medical card, the actual coverage policyholders entitle for in next 10 years, will have minimal difference.
16/01/2024 9:59 AM
wsb_investor https://money.udn.com/money/story/123742/7696251
16/01/2024 5:35 PM
observatory Good sharing. As a principle, a person should not be able to claim more than his actual expenses from his medical insurance policies. Any extra benefits should come from other types like critical illness policies. Isn't that how it should work?
16/01/2024 6:26 PM
wsb_investor you cant fake death or fake critical illness, but very easy to fake hospital admission.
16/01/2024 8:58 PM
observatory What is the implication for AGIC if it eventually win or lose its case against MyCC?
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3415175
17/01/2024 11:29 PM
yielder based on chatgpt's analysis below, allianz is safe
The announcement is about Allianz Malaysia and its insurance subsidiary, AGIC. There was a legal issue with a competition commission (MyCC) accusing them of wrongdoing, but a higher court recently decided in favor of Allianz and other insurers. This means that the legal challenge against them was not successful, and they won the case. So, based on this legal matter, Allianz appears to be in a stable position.
27/01/2024 8:08 PM
yielder Is there any policy Bank negara do to prevent Allianz from getting exposed to junk financial products, that caused AIG to collapse during to Lehman crisis?
27/01/2024 8:10 PM
observatory AIG got into trouble because it recklessly sold “insurance” to other hedge funds betting against the housing market. Such situation does not exist in Malaysia.

Check the types of investments owned by Allianz Malaysia in Note 8 of Annual Report.
28/01/2024 1:07 AM
wsb_investor Malaysia don't have rubbish financial products like the US, but we have rubbish politicians. The only remotely possible way Allianz will bankrupt in near future is government/BNM doesn't allow medical repricing. It took the industry quite a while to make general public and BNM understand that repricing is inevitable, but then I don't think Malaysia politicians will really honor what the previous government has agreed upon and can just u-turn anytime, doing anything for the sake of vote. Looking back past 10 years, insurance companies have been force to donate to mysalam, 70% ownership, delay repricing during covid, donation during covid etc, on top of a general prosperity tax in 2022.
28/01/2024 6:42 PM
yielder government cannot stop medical repricing. Allianz is owned by EU, which has overwhelming negotiation power. Malaysia has greatly benefited from huge EU investment into semi con and aerospace, etc. So repricing is a small price to pay
28/01/2024 7:30 PM
LHT4216148 sorry i just back to stock market , this stock last time suddenly goes so low now come back up .... can i go in ? Will it drop to RM14 or RM17 again ?
27/02/2024 6:30 PM
wsb_investor There is a new guideline on medical insurance by BNM yesterday. BNM push for coinsurance (lower premium, higher margin), and mandate that future reprice premium cannot higher than initial profit margin. BNM also push for a centralized data platform for medical claims.
01/03/2024 9:57 AM
yielder Is Allianz the largest insurer, for medical & investment linked product?
03/03/2024 5:00 PM
wsb_investor No, should be just 4th (by NB volume), 5th by IF volume (HLA 4th). Key difference between HLA and Allianz Life is the proportion of investment linked business (most profitable) over total business.
04/03/2024 9:09 AM
yielder Who are the top 3 for new business & also inforce?
04/03/2024 9:22 AM
PureBULL ... ALLIANZ

ytlp is still the # 1 stock on klse now.
n is followed closely by Utdplt.
n the next up n coming could be Allianz.
its just starting anew...

https://www.tradingview.com/x/M8hpTVvd/
19/03/2024 3:09 PM
troy88 Very steady. For serious investors..
05/04/2024 10:37 AM
observatory @wsb_investor, good sharing on the medical and health insurance policy document.

Before this new policy, are insurers already allowed to market products with co-payment feature? However, as BNM now mandates 5% co-payment (clause 9.4) in new products, it will prevent unhealthy competitions as insurers can no longer entice customers with 100% claim products. By discouraging avoidable claims BNM hopes to lower future premiums.

Similarly, commission limits (Clause 11.1) may have the effect of preventing new insurers from gaining market shares through aggressive sales and marketing.

Therefore the regulations are beneficial to existing players as they discourage cutthroat competitions.

Is this the right understanding?
07/04/2024 1:22 PM
observatory Clause 8.20(a) mentions “The loading shall not exceed 25% of the premium/takaful contribution or COI/tabarru’ rate prior to the claims”.

Does it mean if COI (cost of insurance) including expected claims, management fee, and commissions add up to RM100, the maximum chargeable premium is RM125? In other words, profit before tax margin is capped at 20%.

The effect is on one hand BNM discourage unhealthy competitions, but on the other hand it also prevents insurers from reaping excessive profit.

However, PBT margin capped at 20%, or net margin capped at 15% should be acceptable as historically ALIM PBT margin is in the range of 5% to 10% only?
07/04/2024 1:29 PM
observatory Central medical claims data platform (Clause 12.2) – Does it benefit insurance IT service providers like Rexit?

Coincidentally, Rexit share price has a run-up right after the policy is published on 29-Feb.
07/04/2024 1:30 PM
troy88 Allianz is the insurance king of bursa!
08/04/2024 9:29 AM
sheldon The run up of the price is perhaps a nice big dividend is in the offing?
09/04/2024 3:19 PM
moven00 Lagi Sekali ✅👏🏻….
09/04/2024 10:38 PM
wsb_investor The 25% is only cost of insurance, over paid claims. Not including any expenses. Any previous IFRS4 / IFRS17 profit margin is not meaningful.
10/04/2024 12:53 PM
observatory That means for an expected claim of RM100, premium is capped at RM125. The remaining RM25 (at max) needs to pay off commissions and management fees. Then not much will be left!

In comparison, the general insurance at least offers Allianz a combined ratio of 86%, i.e. underwriting margin is 14%.
10/04/2024 4:34 PM
wsb_investor No, there are other loading for commission and expense. Usually commission is fine, since you will incur as you sold, not much variance there, except for outperformance related. Expenses then a different story. Your expense loading might (and usually) insufficient to meet actual expenses. And the 25% margin for medical, is just expected. Medical service will rise by inflation, rapidly. It might be 25% now, then erode to 15% by year end.
10/04/2024 9:20 PM
observatory Given such challenge, and BNM's caution in approving premium increase, is medical and health insurance a good business relative to other types of insurance? If not, why do insurers still offer such policies instead of freeing up their capital for other types of insurance business?
11/04/2024 7:54 PM
troy88 Allianz will move up to RM30 eventually to join the likes of F&N, Dlady, etc in the RM30+ category..
12/04/2024 9:35 AM
wsb_investor Essentially, for protection business, insurers will earn a x% of total claims payment. And for Malaysia, medical claims are a lot higher than life claims.
12/04/2024 9:15 PM